In Australia, Meridian has signed an agreement with Sydney-based Immuno. For Argentina, Meridian has signed with Scott Pharma, a healthcare distributor. This decision is consistent with Meridian’s stated commitment to expand its non-US businesses.
Todd Motto, vice president of sales and marketing at Meridian Bioscience, said: “Following a thorough evaluation of the Australian and Argentinean markets, it is clear that Immuno and Scott Pharma business models align very well with ours.
“We feel strongly that these are the best partners to ensure expertise in sales, technical support and outstanding customer service. We’re confident that this combination of market expertise and Meridian’s superior quality products will be very successful.”